Knight Therapeutics announces launch of Bijuva in Canada

Knight Therapeutics

6 February 2024 - Knight Therapeutics announced today the launch of Bijuva (oestradiol and progesterone) capsules in Canada.

Bijuva is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with an intact uterus.

Read Knight Therapeutics press release

Michael Wonder

Posted by:

Michael Wonder